STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$7.42
+0.10 (+1.37%)
Open$7.25
Previous Close$7.32
Day High$7.52
Day Low$6.93
52W High$8.33
52W Low$0.76
Volume—
Avg Volume1.05M
Market Cap661.53M
P/E Ratio—
EPS$-0.64
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+562.3% upside
Current
$7.42
$7.42
Target
$49.14
$49.14
$35.75
$49.14 avg
$66.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.33M | 1.16M | 31.76M |
| Net Income | -64,985,191 | -50,664,130 | 1.18M |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% |
| EBITDA | -63,669,551 | -52,396,113 | 2.48M |
| Free Cash Flow | — | — | 903.7K |
| Rev Growth | +15.4% | +15.4% | -3.0% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $258.92 | +3.43% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $425.28 | +1.41% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $143.44 | +3.25% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $528.19 | +2.45% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $810.24 | +0.53% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.61 | +1.79% | 37.6 | 30.39B |